PROCEPT BioRobotics Corporation Proceeds from Debt, Net of Issuance Costs
PROCEPT BioRobotics Corporation (PRCT) reported Proceeds from Debt, Net of Issuance Costs of $3.50 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromDebtNetOfIssuanceCosts · last filed 2025-11-05
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for the quarter ending 2025-09-30 was -$1.00K.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for the quarter ending 2024-12-31 was -$2.12M.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for the quarter ending 2024-09-30 was $0.00.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for the quarter ending 2021-12-31 was $0.00.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for fiscal 2024 was $0.00.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for fiscal 2022 was $51.20M.
- PROCEPT BioRobotics Corporation proceeds from debt, net of issuance costs for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Proceeds from Debt, Net of Issuance Costs 3 month | Proceeds from Debt, Net of Issuance Costs 6 month | Proceeds from Debt, Net of Issuance Costs 9 month | Proceeds from Debt, Net of Issuance Costs 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.50M 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $3.50M 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | -$2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$2.12M derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-K · filed 2025-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.12M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $2.12M 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $51.20M 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-05 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $24.68M 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $24.68M 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |